MedPath

Insulin Secretory Capacity in Insulin-independent Pancreas-Kidney Recipients Compared to Controls

Not Applicable
Conditions
Kidney Transplantation
Pancreas Transplantation
Registration Number
NCT00618761
Lead Sponsor
University Hospital, Gasthuisberg
Brief Summary

The purpose of this study is to compare functional beta-cell mass using the hyperglycaemic clamp test in insulin-independent pancreas-kidney recipients with that in non-diabetic kidney recipients and normal controls as well as with the partially previously reported data in beta-cell recipients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • kidney pancreas recipients
  • kidney recipients
  • healthy volunteers
  • beta-cell recipients
  • immunosuppression with MMF-Tacrolimus
  • 1-4 years after transplantation
Exclusion Criteria
  • high doses of steroids
  • insulin dependent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
insulin secretion during clamp testtime 0
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Endocrinology, Leuven, UZ-Gasthuisberg

🇧🇪

Leuven, Belgium

Department of Endocrinology, Leuven, UZ-Gasthuisberg
🇧🇪Leuven, Belgium
Pieter Gillard, M.D.
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.